86 related articles for article (PubMed ID: 25410042)
1. The frequency of the BLM*p.Q548X (c.1642C > T) mutation in breast cancer patients from Russia.
Imyanitov E; Prokofyeva D; Bogdanova N; Dörk T
Breast Cancer Res Treat; 2014 Dec; 148(3):695-6. PubMed ID: 25410042
[No Abstract] [Full Text] [Related]
2. The frequency of the BLM p.Q548X (c.1642C>T) mutation in breast cancer patients from Russia is no higher than in the general population.
Anisimenko MS; Kozyakov AE; Paul GA; Kovalenko SP
Breast Cancer Res Treat; 2014 Dec; 148(3):689-90. PubMed ID: 25399228
[No Abstract] [Full Text] [Related]
3. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
[TBL] [Abstract][Full Text] [Related]
4. Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations.
Prokofyeva D; Bogdanova N; Dubrowinskaja N; Bermisheva M; Takhirova Z; Antonenkova N; Turmanov N; Datsyuk I; Gantsev S; Christiansen H; Park-Simon TW; Hillemanns P; Khusnutdinova E; Dörk T
Breast Cancer Res Treat; 2013 Jan; 137(2):533-9. PubMed ID: 23225144
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe.
Bogdanova N; Togo AV; Ratajska M; Kluźniak W; Takhirova Z; Tarp T; Prokofyeva D; Bermisheva M; Yanus GA; Gorodnova TV; Sokolenko AP; Kuźniacka A; Podolak A; Stukan M; Wokołorczyk D; Gronwald J; Vasilevska D; Rudaitis V; Runnebaum IB; Dürst M; Park-Simon TW; Hillemanns P; Antonenkova N; Khusnutdinova E; Limon J; Lubinski J; Cybulski C; Imyanitov E; Dörk T
Fam Cancer; 2015 Mar; 14(1):145-9. PubMed ID: 25182961
[TBL] [Abstract][Full Text] [Related]
6. High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.
Sokolenko AP; Iyevleva AG; Preobrazhenskaya EV; Mitiushkina NV; Abysheva SN; Suspitsin EN; Kuligina ESh; Gorodnova TV; Pfeifer W; Togo AV; Turkevich EA; Ivantsov AO; Voskresenskiy DV; Dolmatov GD; Bit-Sava EM; Matsko DE; Semiglazov VF; Fichtner I; Larionov AA; Kuznetsov SG; Antoniou AC; Imyanitov EN
Int J Cancer; 2012 Jun; 130(12):2867-73. PubMed ID: 21815139
[TBL] [Abstract][Full Text] [Related]
7. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
[TBL] [Abstract][Full Text] [Related]
8. RECQL: a DNA helicase in breast cancer.
Akbari MR; Cybulski C
Oncotarget; 2015 Sep; 6(29):26558-9. PubMed ID: 26387136
[No Abstract] [Full Text] [Related]
9. Reply to 'Mutations in RECQL are not associated with breast cancer risk in an Australian population'.
Ahmed H; Lerner-Ellis J; Cybulski C; Metcalfe K; Lubiński J; Narod SA; Akbari MR
Nat Genet; 2018 Oct; 50(10):1348-1349. PubMed ID: 30224648
[No Abstract] [Full Text] [Related]
10. Mutations in RECQL are not associated with breast cancer risk in an Australian population.
Li N; Rowley SM; Goode DL; Amarasinghe KC; McInerny S; Devereux L; ; Wong-Brown MW; Lupat R; Lee JEA; Hughes S; Thompson ER; Zethoven M; Li J; Trainer AH; Gorringe KL; Scott RJ; James PA; Campbell IG
Nat Genet; 2018 Oct; 50(10):1346-1348. PubMed ID: 30224651
[No Abstract] [Full Text] [Related]
11. Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility.
Ding SL; Yu JC; Chen ST; Hsu GC; Kuo SJ; Lin YH; Wu PE; Shen CY
Carcinogenesis; 2009 Jan; 30(1):43-9. PubMed ID: 18974064
[TBL] [Abstract][Full Text] [Related]
12. First Two Cases of Bloom Syndrome in Russia: Lack of Skin Manifestations in a
Suspitsin EN; Sibgatullina FI; Lyazina LV; Imyanitov EN
Mol Syndromol; 2017 Mar; 8(2):103-106. PubMed ID: 28611551
[TBL] [Abstract][Full Text] [Related]
13. A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women.
Wang Z; Xu Y; Tang J; Ma H; Qin J; Lu C; Wang X; Hu Z; Wang X; Shen H
Breast Cancer Res Treat; 2009 Nov; 118(1):169-75. PubMed ID: 19205873
[TBL] [Abstract][Full Text] [Related]
14. Germline RECQL mutations are associated with breast cancer susceptibility.
Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous mutations in DNA repair genes and hereditary breast cancer: a question of power.
Ellis NA; Offit K
PLoS Genet; 2012 Sep; 8(9):e1003008. PubMed ID: 23028381
[No Abstract] [Full Text] [Related]
16. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
[TBL] [Abstract][Full Text] [Related]
17. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
[TBL] [Abstract][Full Text] [Related]
18. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.
Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
[TBL] [Abstract][Full Text] [Related]
19. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
[TBL] [Abstract][Full Text] [Related]
20. Human RECQ Helicase Pathogenic Variants, Population Variation and "Missing" Diseases.
Fu W; Ligabue A; Rogers KJ; Akey JM; Monnat RJ
Hum Mutat; 2017 Feb; 38(2):193-203. PubMed ID: 27859906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
